Your browser doesn't support javascript.
loading
Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis.
Däster, Silvio; Eppenberger-Castori, Serenella; Hirt, Christian; Soysal, Savas D; Delko, Tarik; Nebiker, Christian A; Weixler, Benjamin; Amicarella, Francesca; Iezzi, Giandomenica; Governa, Valeria; Padovan, Elisabetta; Mele, Valentina; Sconocchia, Giuseppe; Heberer, Michael; Terracciano, Luigi; Kettelhack, Christoph; Oertli, Daniel; Spagnoli, Giulio C; von Holzen, Urs; Tornillo, Luigi; Droeser, Raoul A.
Afiliación
  • Däster S; Department of Surgery; University Hospital Basel ; Basel, Switzerland ; Institute of Surgical Research and Hospital Management, Department of Biomedicine; University of Basel , Basel, Switzerland.
  • Eppenberger-Castori S; Institute of Pathology; University Hospital Basel ; Basel, Switzerland.
  • Hirt C; Department of Surgery; University Hospital Basel ; Basel, Switzerland ; Institute of Surgical Research and Hospital Management, Department of Biomedicine; University of Basel , Basel, Switzerland.
  • Soysal SD; Department of Surgery; University Hospital Basel ; Basel, Switzerland ; Institute of Surgical Research and Hospital Management, Department of Biomedicine; University of Basel , Basel, Switzerland.
  • Delko T; Department of Surgery; University Hospital Basel ; Basel, Switzerland.
  • Nebiker CA; Department of Surgery; University Hospital Basel ; Basel, Switzerland ; Institute of Surgical Research and Hospital Management, Department of Biomedicine; University of Basel , Basel, Switzerland.
  • Weixler B; Department of Surgery; University Hospital Basel ; Basel, Switzerland.
  • Amicarella F; Institute of Surgical Research and Hospital Management, Department of Biomedicine; University of Basel , Basel, Switzerland.
  • Iezzi G; Institute of Surgical Research and Hospital Management, Department of Biomedicine; University of Basel , Basel, Switzerland.
  • Governa V; Institute of Surgical Research and Hospital Management, Department of Biomedicine; University of Basel , Basel, Switzerland.
  • Padovan E; Institute of Surgical Research and Hospital Management, Department of Biomedicine; University of Basel , Basel, Switzerland.
  • Mele V; Institute of Surgical Research and Hospital Management, Department of Biomedicine; University of Basel , Basel, Switzerland.
  • Sconocchia G; Institute of Translational Pharmacology, Department of Biomedicine; National Research Council , Rome, Italy.
  • Heberer M; Institute of Surgical Research and Hospital Management, Department of Biomedicine; University of Basel , Basel, Switzerland.
  • Terracciano L; Institute of Pathology; University Hospital Basel ; Basel, Switzerland.
  • Kettelhack C; Department of Surgery; University Hospital Basel ; Basel, Switzerland.
  • Oertli D; Department of Surgery; University Hospital Basel ; Basel, Switzerland.
  • Spagnoli GC; Institute of Surgical Research and Hospital Management, Department of Biomedicine; University of Basel , Basel, Switzerland.
  • von Holzen U; Department of Surgery; University Hospital Basel ; Basel, Switzerland ; Indiana University School of Medicine South Bend, Indiana University Health Goshen Center for Cancer Care , Goshen, IN, USA.
  • Tornillo L; Institute of Pathology; University Hospital Basel ; Basel, Switzerland.
  • Droeser RA; Department of Surgery; University Hospital Basel ; Basel, Switzerland ; Institute of Surgical Research and Hospital Management, Department of Biomedicine; University of Basel , Basel, Switzerland.
Oncoimmunology ; 4(12): e1050574, 2015 Dec.
Article en En | MEDLINE | ID: mdl-26587320
ABSTRACT
Colorectal cancer (CRC) infiltration by cells expressing myeloperoxidase (MPO) or CD8 positive T lymphocytes has been shown to be independently associated with favorable prognosis. We explored the relationship occurring between CD8+ and MPO+ cell CRC infiltration, its impact on clinical-pathological features and its prognostic significance in a tissue microarray (TMA) including 1,162 CRC. We observed that CRC showing high MPO+ cell infiltration are characterized by a prognosis as favorable as that of cancers with high CD8+ T cell infiltration. However, MPO+ and CD8+ CRC infiltrating cells did not synergize in determining a more favorable outcome, as compared with cancers showing MPOhigh/CD8low or MPOlow/CD8high infiltrates. Most importantly, we identified a subgroup of CRC with MPOlow/CD8low tumor infiltration characterized by a particularly severe prognosis. Intriguingly, although MPO+ and CD8+ cells did not co-localize in CRC infiltrates, an increased expression of TIA-1 and granzyme-B was detectable in T cells infiltrating CRC with high MPO+ cell density.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncoimmunology Año: 2015 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncoimmunology Año: 2015 Tipo del documento: Article País de afiliación: Suiza